The Former Partner on the Panel: Recusal, Default, and the Scope of a Board Subpoena
A complaint filed with the Department of Public Health alleges that Dr. Reyes billed for comprehensive examinations he did not perform and abandoned roughly 40 patients when he closed a satellite office without notice. The matter is scheduled for a contested hearing before the Board of Examiners for Optometrists. One Board member, Dr. Lin, was Dr. Reyes's business partner in a practice that dissolved acrimoniously three years ago; she has not recused herself from the panel and has been active in questioning witnesses. Dr. Reyes objects through counsel and asks that she be removed. He then fails to appear at the hearing. His attorney later explains that the notice went to an office address he closed two years earlier, although he never told DPH the address had changed and never arranged forwarding. During the investigation, the Board's investigator subpoenaed the complete treatment records of 15 patients of the practice who never filed complaints.
1. Should Dr. Lin have recused herself, and what are the consequences if she did not?
Read the worked answer
Yes. A licensing hearing must be decided by an impartial panel. Dr. Lin is not merely a professional acquaintance; she was a business partner in a practice that ended badly, which creates both a plausible personal stake and, at minimum, an appearance of bias that a reviewing court will scrutinize.
The applicable standard is not whether she actually prejudged the case, but whether a reasonable observer would question her neutrality. Her active questioning of witnesses aggravates the problem because it puts her advocacy on the record. The Board's counsel should have screened the conflict before the hearing and substituted an alternate member.
If she participated in the deliberations or the vote, Dr. Reyes can raise the taint on appeal under the Uniform Administrative Procedure Act, and the final order may be remanded for a new hearing. The practical lesson for the Board is to run a conflict check on every panel member at the outset and to document recusal decisions.
2. May the hearing proceed in Dr. Reyes's absence, and what must the record show?
Read the worked answer
Generally yes, provided the notice was legally sufficient. A licensee cannot defeat a proceeding by failing to appear, and a licensee has an affirmative duty to keep DPH informed of a current mailing address. Notice sent to the address of record, in the manner the statutes require, normally satisfies due process even if the licensee never received it in fact because he moved and left no forwarding arrangement.
The record must show what address was used, how the notice was sent, when it was sent, and that it was not returned as undeliverable without follow-up. If the agency knew the address was stale, the analysis shifts.
The remedy for Dr. Reyes is not to ignore the order but to move promptly to reopen, showing good cause for the absence and a meritorious defense, and then to pursue an administrative appeal if that motion is denied. Waiting until after the sanction issues weakens both arguments considerably.
3. Can the Board obtain records of patients who never complained? What limits apply?
Read the worked answer
Yes, within limits. The Board's investigative authority extends to records reasonably relevant to the allegations. If the complaint is that Dr. Reyes billed for examinations he did not perform, the charts of patients he saw during the relevant period are the primary evidence, and the fact that those patients did not complain does not make the records irrelevant or privileged.
Patient confidentiality is not absolute against a lawful regulatory subpoena, but it is not erased either. Production should be limited to what the investigation actually needs, redacted where unrelated sensitive information is not relevant, protected from unnecessary public disclosure, and, where practicable, patients should be told that their records were produced.
If the subpoena sweeps in records with no connection to the allegations, the licensee can move to quash or narrow it. The Board should also be able to articulate why 15 charts rather than 4 or 40 were required.